RxDoctor Payments Data

Garrett Jensen, MD

Radiation Oncology · Indianapolis, INNPI 1669908125

Payments from drug & device makers

What this record shows

GT Medical Technologies, Inc accounts for 66.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $3,319 and has fallen 66.8% since, to $1,101 in 2025. Among radiation oncology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,446in general payments, 2019–2025

Across 45 payments — averaging $98.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$3K
  • AstraZeneca$516
  • Regeneron Healthcare Solutions, Inc.$250
  • Stemline Therapeutics Inc.$156
  • Icotec Medical Inc.$145
  • Novartis$55
  • plus $389 from 17 others

What the payments were for

  • Travel & lodging$2,09047%
  • Food & beverage$2,35653%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,446 in reported general payments places this provider in the 90th percentile of 116 radiation oncology providers in Indiana.

See all radiation oncology providers in Indiana

Medicare billing

Part B allowed, 2024
$195,843
Medicare patients
213
Services billed
2,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone13$384
Lidocaine Hcl ViscousLidocaine Hcl13$249
Mometasone Furoate13$199
Prednisone20$115

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →